Physician profile
Sarah E Henry
NPI 1265693568
$4,345.59
in general payments reported to CMS, 2019-2025
14 companies · $1,140 in 2025
The $1,140 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $64.51 · 2021: $124 · 2022: $1,520 · 2023: $1,226 · 2024: $154 · 2025: $1,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569 · Travel and Lodging: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,569.29 |
| Travel and Lodging | $951.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $2,095.77 | 2023-2025 | |
| Arthrex, INC. | $1,502.40 | 2022 | |
| Axogen | $245.50 | 2019-2025 | Avance Nerve Graft |
| Endo USA, INC. | $125.66 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $104.75 | 2019-2023 | Xiaflex |
| Horizon Therapeutics Plc | $51.36 | 2021 | |
| Integra Lifesciences Corporation | $48.56 | 2020 | |
| Reel Surgical, INC. | $29.57 | 2025 | |
| Bioventus LLC | $28.70 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Zimmer Biomet Holdings, INC. | $28.33 | 2020-2021 | |
| Checkpoint Surgical, INC | $25.82 | 2025 | Checkpoint Stimulators |
| Medartis INC. | $22.42 | 2019 | |
| Reprise Biomedical, INC. | $19.17 | 2025 | Mirodry |
| Orthofix Medical, INC. | $17.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.